Docoh
Loading...

ATHE Alterity Therapeutics

766 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
6-K
ATHE Alterity Therapeutics Ltd
22 Nov 21
Alterity Therapeutics to Participate in Two Upcoming Investor Conferences
6:09am
6-K
ATHE Alterity Therapeutics Ltd
12 Nov 21
Results of Annual General Meeting
6:07am
6-K
ATHE Alterity Therapeutics Ltd
12 Nov 21
Report of Foreign Private Issuer
6:05am
6-K
ATHE Alterity Therapeutics Ltd
12 Nov 21
Report of Foreign Private Issuer
6:01am
6-K
ATHE Alterity Therapeutics Ltd
9 Nov 21
Alterity Therapeutics Announces Presentation of ATH434 at the American Autonomic Society Virtual Meeting 2021
7:30am
6-K
ATHE Alterity Therapeutics Ltd
4 Nov 21
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases
6:05am
6-K
ATHE Alterity Therapeutics Ltd
29 Oct 21
Appendix 4C – Q1 FY22 Quarterly Cash Flow Report
6:04am
6-K
ATHE Alterity Therapeutics Ltd
18 Oct 21
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program
8:00pm
6-K
ATHE Alterity Therapeutics Ltd
12 Oct 21
Notice of Annual General Meeting and Explanatory Memorandum
6:09am
6-K
ATHE Alterity Therapeutics Ltd
20 Sep 21
Alterity Announces Presentation of Biomarker Data at the International Parkinson and Movement Disorder Society Congress 2021
6:06am
6-K
ATHE Alterity Therapeutics Ltd
3 Sep 21
Report of Foreign Private Issuer
6:15am
6-K
ATHE Alterity Therapeutics Ltd
3 Sep 21
Report of Foreign Private Issuer
6:12am
6-K
ATHE Alterity Therapeutics Ltd
3 Sep 21
Report of Foreign Private Issuer
6:09am
20-F
2021 FY
ATHE Alterity Therapeutics Ltd
2 Sep 21
Annual report (foreign)
6:34am
6-K
ATHE Alterity Therapeutics Ltd
4 Aug 21
Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds
6:07am
6-K
ATHE Alterity Therapeutics Ltd
30 Jul 21
Appendix 4C – Q4 FY21 Quarterly Cash Flow Report
6:12am
6-K
ATHE Alterity Therapeutics Ltd
15 Jul 21
Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is
6:07am
SC 13D/A
Life Biosciences LLC
8 Jul 21
ALTERITY THERAPEUTICS / Life Biosciences ownership change
4:21pm
6-K
ATHE Alterity Therapeutics Ltd
6 Jul 21
Report of Foreign Private Issuer
6:17am
6-K
ATHE Alterity Therapeutics Ltd
6 Jul 21
Report of Foreign Private Issuer
6:07am